Application of Acyzol in the Context of Zinc Deficiency and Perspectives

The document discussed the application of Acyzol, a zinc-containing compound, in addressing zinc deficiency and its broader therapeutic effects. Zinc is essential for numerous biological functions, and its deficiency affects over 2 billion people globally, leading to various health issues, including alopecia and psoriasis. Acyzol showed high bioavailability, low toxicity, and good tolerability, effectively improving neuropsychiatric functions, reducing coronary artery disease symptoms, and shortening cold symptoms. It also demonstrated significant antidotal properties against carbon monoxide poisoning and potential in treating toxicohypoxic encephalopathies and skin diseases. Clinical studies indicated its efficacy in reducing pneumonia mortality and providing cardioprotective effects. The research concluded that Acyzol is a highly effective drug for treating hypoxia, toxicohypoxic encephalopathy, periodontal, immune, and heart pathologies, and holds promise for treating and preventing zinc deficiency conditions.